用于治疗勃起功能障碍的 Li-ESWT 冲击波疗法

Focused low-intensity acoustic shockwaves are delivered to the penile shaft and crura through a handheld applicator. The mechanical stimulus triggers a cascade of cellular responses - recruitment of endothelial progenitor cells, upregulation of VEGF and other growth factors, and proliferation of new microvasculature in the cavernosal tissue.

临床目标是 恢复 勃起功能，而非提供即时效果。与PDE5抑制剂不同，Li-ESWT作用于潜在的血管基质，旨在实现疗程之间及疗程结束后持续的改善。

每次治疗耗时15-20分钟，无需麻醉，且无恢复期。大多数男性可立即恢复正常活动，包括运动。

最有力的证据支持Li-ESWT用于血管性勃起功能障碍（ED）的男性，特别是65岁以下、对PDE5抑制剂反应不佳或无反应的患者。它能使相当一部分PDE5无反应者转变为反应者。

对于患有严重糖尿病相关微血管损伤、根治性前列腺切除术后神经损伤或终末期动脉粥样硬化的男性，其疗效较差。Hisential的评估流程包括血管和代谢检查，以确保治疗资格与机制匹配，而非仅凭个人意愿。

Hisential的典型疗程为6周内进行6-12次治疗。改善通常在第3-4次治疗后开始，并在疗程结束后持续数月。最大规模的荟萃分析（见下方参考文献）报告称，在筛选合适的男性中，60-70%的人IIEF-EF评分有临床意义的改善，且效果在12-24个月甚至更长时间内保持持久。

Li-ESWT与优化的PDE5剂量和代谢方案配合使用效果良好。许多男性随后可以减少PDE5剂量或改为按需使用。

在已发表的研究中，Li-ESWT具有极佳的安全性。最常见的报告是轻微的短暂触痛、偶尔的轻微淤青和短暂的皮肤发红。在随机试验中，没有严重不良事件被可靠地归因于针对ED的聚焦式Li-ESWT。

在患有活动性阴茎感染、治疗区域有活动性恶性肿瘤或患有出血性疾病的男性中，不宜进行此治疗。您的主治医生会在安排任何疗程前评估适用性。

All figures below are inclusive of GST.

Prices last updated 13 August 2026. Prices include GST unless stated otherwise and are confirmed by your concierge before anything is booked.

• Introductory session: from S$150. This is the price of the introductory Li-ESWT session.
• Within a package: S$350 per session. After the introductory session, Li-ESWT is sold in packages. S$350 is the per-session rate inside a package. There is no single-session rate, so this figure is not a walk-in price for one session.
• Consultation: from S$50 after GST.
• Teleconsultation for follow-ups: from S$50 after GST.

Your package is sized to the course your doctor recommends after assessment, so the total depends on the number of sessions agreed. Where Li-ESWT is combined with oral medication or hormonal treatment, those are quoted separately and clearly.

A complete clinical episode at Hisential is structured around four clearly-defined stages, so patients understand what to expect at each visit and how decisions are made.

Stage 1 - Pre-consultation triage. Before your first appointment about Li-ESWT, our care coordinators take a brief history by WhatsApp or phone to determine whether teleconsultation, an in-clinic visit, or a same-day workup is most appropriate. This avoids unnecessary travel for issues that can be triaged remotely, and ensures patients with urgent presentations are prioritised. Where laboratory tests, imaging, or fasting are likely to be needed, we explain the requirements in advance so the first visit is productive rather than purely exploratory.

Stage 2 - In-clinic assessment. The first consultation includes a structured medical history, focused examination, and, where clinically indicated, point-of-care or laboratory investigations. Doctors document findings in our digital records system and walk patients through the rationale for each test. Costs are confirmed before any chargeable investigation is performed; nothing is added without consent.

Stage 3 - Diagnosis, plan, and shared decision-making. Once results are available, the doctor reviews them with the patient in plain language, including normal ranges, areas of concern, and the level of evidence behind any proposed intervention. For Li-ESWT, treatment options are framed in terms of expected benefit, realistic timelines, side-effect profile, and cost. Patients are encouraged to ask questions and may request a second appointment to consider their options before starting treatment; there is no pressure to decide on the day.

Stage 4 - Follow-up and continuity. Follow-up intervals are agreed at the end of the first visit and depend on the condition: chronic management is typically reviewed every 3-6 months, while acute episodes may be reviewed within 1-4 weeks. Teleconsultation (from S$50 after GST) is offered for routine follow-ups where physical examination is not required. Records are retained securely and remain accessible to the patient on request, including for onward referral or coordination with another doctor.

Hisential does not sell unproven therapies, does not recommend tests without a clinical indication, and does not extend treatment courses beyond what the evidence supports. If a condition falls outside our scope - for example, requiring inpatient care, surgical sub-specialty input, or oncology services - we say so and refer appropriately. Honest scope is part of the standard.